|
⚲
|
| Keyboard |
| Gladney Dan W
✚
|
|
|---|---|
| CIK # | 0001224184 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001224184] | |
| 4 | [0001224184] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Gladney Dan W | |
| Obalon Therapeutics Inc | |
| EnteroMedics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Obalon Therapeutics Inc RSLS
Common Stock, $0.001 par value per share
|
2021-09-10 | Sell | 200,000 | $2.99 | 598,000 |
|
Obalon Therapeutics Inc RSLS
Common Stock, $0.001 par value per share
|
2021-07-22 | Grant | 483,922 | $0.00 | |
|
EnteroMedics Inc RSLS
Stock Option (right to buy) · derivative
|
2018-04-18 | Grant | 4,164,281 | $0.00 | |
|
EnteroMedics Inc ETRM
Stock Option (right to buy) · derivative
|
2017-10-06 | Grant | 662,975 | $0.00 | |
|
EnteroMedics Inc ETRM
Stock Option (right to buy) · derivative
|
2017-02-08 | Grant | 466,500 | $0.00 | |
|
EnteroMedics Inc ETRM
Common Stock
|
2015-11-12 | Buy | 750,000 | $0.18 | 135,000 |
|
EnteroMedics Inc ETRM
Stock Option (right to buy) · derivative
|
2015-10-28 | Grant | 7,750,000 | $0.00 | |
|
EnteroMedics Inc ETRM
Common Stock
|
2015-05-16 | Buy | 84,745 | $0.72 | 61,016 |